Caption Management, LLC Contrafect Corp Call Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.18 - $3.51 $69,156 - $1.35 Million	384,200 Added 333.22%	499,500 $85,000
Q2 2022 Aug 15, 2022	BUY	$2.79 - $4.45 $120,528 - $192,240	43,200 Added 59.92%	115,300 $354,000
Q1 2022 May 13, 2022	BUY	$2.26 - $3.84 $117,745 - $200,064	52,100 Added 260.5%	72,100 $263,000
Q3 2021 Nov 12, 2021	BUY	$3.19 - $4.43 $63,800 - $88,600	20,000 New	20,000 $81,000

49.2K

Ticker CFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,332,700
Market Cap $1.18M
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.